A randomized, double-masked, placebo-controlled parallel study of loteprednol etabonate 0.2% in patients with seasonal allergic conjunctivitis11None of the investigators had a proprietary interest in loteprednol etabonate

Saved in:
Bibliographic Details
Published inOphthalmology (Rochester, Minn.) Vol. 106; no. 2; pp. 362 - 369
Main Authors Shulman, David G, Lothringer, Larry L, Rubin, Jay M, Briggs, Richard B, Howes, John, Novack, Gary D, Hart, Kathryn
Format Journal Article
LanguageEnglish
Published 01.02.1999
Online AccessGet full text

Cover

More Information
ISSN:0161-6420
DOI:10.1016/S0161-6420(99)90077-5